Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25787719 |
US |
37 | 2 |
Paraesthesia, Restlessness, Fatigue, Schizophrenia, Intentional product misuse, Product use in unapproved indication, Headache, Hallucination, Vomiting, Abnormal behaviour, Emotional disorder, Delusion, Disorientation, |
||||
LEVONORGESTREL, MAGNESIUM, |
||||
| 402 | 25787741 |
CA |
2 | |
COVID-19, Circumstance or information capable of leading to medication error, Concussion, Cough, Discomfort, Fatigue, Head injury, Headache, Hypoaesthesia, Loss of consciousness, Mania, Nasal congestion, Nasopharyngitis, Nausea, Oropharyngeal pain, Pain, Pain in extremity, Paraesthesia, Product distribution issue, Product dose omission issue, Pyrexia, |
||||
METHYLPHENIDATE HYDROCHLORIDE, LEMBOREXANT, ADALIMUMAB-FKJP, DULOXETINE HYDROCHLORIDE, DULOXETINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 403 | 25787983 |
CA |
73 | 2 |
Abdominal pain, Burning sensation, Cold sweat, Diarrhoea, Fatigue, General physical health deterioration, Hallucination, Headache, Latent tuberculosis, Maculopathy, Oropharyngeal pain, Paraesthesia, Therapy partial responder, Myalgia, Pain, Musculoskeletal stiffness, Off label use, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, HYDROXYCHLOROQUINE, RIFAMPIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 404 | 25788552 |
EU |
1 | |
Hypotonia, Paraesthesia, |
||||
NITROUS OXIDE, |
||||
| 405 | 25788619 |
GB |
27 | 2 |
Menstruation delayed, Erythema, Rash erythematous, Constipation, Arthralgia, Myalgia, Fatigue, Paraesthesia, Asthenia, Chills, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 406 | 25788753 |
US |
2 | |
Heavy menstrual bleeding, Menstruation irregular, Injection site pain, Gingival pain, Gingival bleeding, Paraesthesia, Hypoaesthesia, Vasoconstriction, Muscle spasms, Feeling hot, ADAMTS13 activity decreased, Fatigue, |
||||
CAPLACIZUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 407 | 25775196 |
GB |
2 | |
Neuropathy peripheral, Paraesthesia, Nausea, Constipation, Diarrhoea, |
||||
BUPRENORPHINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GABAPENTIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, BUPRENORPHINE, |
||||
| 408 | 25775213 |
US |
2 | |
Pruritus, Urticaria, Chest pain, Abdominal pain, Paraesthesia, |
||||
SODIUM FERRIC GLUCONATE COMPLEX, |
||||
| 409 | 25775357 |
US |
2 | |
Panic attack, Movement disorder, Muscle tightness, Sensation of foreign body, Anxiety, Paraesthesia, Sleep disorder, Malaise, Product quality issue, |
||||
CLONAZEPAM, CLONAZEPAM, |
||||
| 410 | 25775454 |
EU |
59 | 1 |
Skin toxicity, Paraesthesia, Diarrhoea, Mucosal inflammation, Nausea, |
||||
CARBOPLATIN, PEMBROLIZUMAB, PACLITAXEL, |
||||
| 411 | 25775758 |
US |
||
Immunosuppression, Neuropathy peripheral, Headache, Ocular discomfort, Onychoclasis, Dry skin, Dysphagia, Fatigue, White blood cell count decreased, Red blood cell count decreased, Paraesthesia, Haemoglobin decreased, Stomatitis, Oral pain, Nausea, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 412 | 25776108 |
EU |
||
Muscle spasms, Paraesthesia, Pain in extremity, Musculoskeletal stiffness, Muscle spasticity, Device malfunction, |
||||
BACLOFEN, |
||||
| 413 | 25776364 |
US |
2 | |
Wrong technique in product usage process, Treatment noncompliance, Ocular discomfort, Facial pain, Paraesthesia, Eye pain, |
||||
CENEGERMIN-BKBJ, PERFLUOROHEXYLOCTANE, CYCLOSPORINE OPHTHALMIC SOLUTION, VARENICLINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SERTRALINE HYDROCHLORIDE, LIDOCAINE PATCH 5%, DULOXETINE HYDROCHLORIDE, FISH OIL, SENNOSIDES, SENNA LEAF, SENNA, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ALBUTEROL SULFATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ALPRAZOLAM, |
||||
| 414 | 25777264 |
EU |
2 | |
Ear discomfort, Disturbance in attention, Chest pain, Paraesthesia, Headache, Fatigue, Loss of personal independence in daily activities, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 415 | 25777714 |
IN |
55 | 2 |
Lower limb fracture, Taste disorder, Back pain, Decreased appetite, Sleep disorder, Paraesthesia, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 416 | 25777718 |
GB |
2 | |
Neuropathy peripheral, Paraesthesia, Constipation, Nausea, Diarrhoea, |
||||
BUPRENORPHINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BUPRENORPHINE, |
||||
| 417 | 25778188 |
US |
1 | |
Burning sensation, Paraesthesia, |
||||
CAPSAICIN, |
||||
| 418 | 25778630 |
EU |
34 | 2 |
Neutropenia, Muscle spasms, Asthenia, Anaemia, Erythema, Epistaxis, Paraesthesia, Injection site pain, Dyspnoea exertional, Gastrointestinal disorder, |
||||
PACLITAXEL, PEMBROLIZUMAB, CARBOPLATIN, |
||||
| 419 | 25778662 |
EU |
60 | 2 |
Presyncope, Cough, Rash, Rhinitis, Myalgia, Epistaxis, Anaemia, Hyperkalaemia, Constipation, Abdominal pain, Dysaesthesia, Weight decreased, Asthenia, Neutropenia, Paraesthesia, Gastrointestinal disorder, |
||||
PACLITAXEL, PEMBROLIZUMAB, CARBOPLATIN, |
||||
| 420 | 25779052 |
BR |
2 | |
Hemiparesis, Treatment failure, Paraesthesia, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 421 | 25779150 |
CA |
35 | 2 |
Burning sensation, Hypoaesthesia, Insomnia, Nerve compression, Paraesthesia, |
||||
USTEKINUMAB, |
||||
| 422 | 25779325 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back disorder, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Discomfort, Drug hypersensitivity, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Lip dry, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Myositis, Nail disorder, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Abdominal pain upper, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Infusion site reaction, Live birth, Liver injury, Neck pain, Onychomadesis, Paraesthesia, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Type 2 diabetes mellitus, Systemic lupus erythematosus, Intentional product use issue, Drug intolerance, Maternal exposure during pregnancy, Off label use, Drug ineffective, Product use in unapproved indication, Product use issue, Treatment failure, Therapeutic product effect incomplete, |
||||
LEFLUNOMIDE, HYDROXYCHLOROQUINE, SARILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 423 | 25779763 |
US |
||
Paraesthesia, Dysphagia, |
||||
TIRZEPATIDE, |
||||
| 424 | 25779859 |
US |
69 | 2 |
Liver function test abnormal, Cytokine release syndrome, Hypoxia, Lymphocytosis, Neutropenia, Pain, Paraesthesia, Muscular weakness, Gait disturbance, Tremor, Reduced facial expression, Fatigue, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 425 | 25779884 |
US |
2 | |
Obesity, Arthralgia, Pain in extremity, Paraesthesia, Drug ineffective, Product use in unapproved indication, |
||||
SECUKINUMAB, SECUKINUMAB, DIVALPROEX SODIUM, DIVALPROEX SODIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FOLIC ACID, FOLIC ACID, HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NABUMETONE, NABUMETONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 426 | 25780386 |
US |
2 | |
Joint stiffness, Paraesthesia, Dyspnoea, |
||||
SODIUM FERRIC GLUCONATE COMPLEX, |
||||
| 427 | 25780399 |
US |
16 | 1 |
Paraesthesia, Haemoglobin abnormal, |
||||
DUPILUMAB, |
||||
| 428 | 25780672 |
EU |
60 | 2 |
Presyncope, Neutropenia, Hyperkalaemia, Gastrointestinal disorder, Abdominal pain, Weight decreased, Epistaxis, Paraesthesia, Cough, Rhinitis, Asthenia, Rash, Myalgia, Constipation, Dysaesthesia, Anaemia, |
||||
PACLITAXEL, CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 429 | 25780867 |
CA |
72 | 2 |
Adverse event, Arthralgia, Back pain, Bursitis, Deafness, Disease progression, Disease recurrence, Drug intolerance, Electric shock sensation, Feeling abnormal, Gait disturbance, Hypoaesthesia, Inflammation, Inflammatory marker increased, Joint swelling, Limb discomfort, Movement disorder, Musculoskeletal discomfort, Musculoskeletal stiffness, Neck pain, Nerve compression, Pain, Pain in extremity, Pain in jaw, Polyarthritis, Dry mouth, Glomerular filtration rate decreased, Headache, Hypersensitivity, Blood creatinine increased, Paraesthesia, Tachycardia, Tinnitus, |
||||
DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LOSARTAN POTASSIUM, LOSARTAN, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 430 | 25786689 |
65 | 2 | |
Diarrhoea, Dehydration, Fatigue, Paraesthesia, Burning sensation, |
||||
AVACOPAN, |
||||
| 431 | 25770578 |
US |
1 | |
Loss of consciousness, Dizziness, Paraesthesia, |
||||
FRUQUINTINIB, FRUQUINTINIB, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE GEL USP, 1%, CLINDAMYCIN PHOSPHATE TOPICAL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, POTASSIUM PHOSPHATE, MONOBASIC, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE MALEATE, RIVAROXABAN, |
||||
| 432 | 25770828 |
US |
||
Paraesthesia, Nausea, |
||||
PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, |
||||
| 433 | 25771759 |
CA |
||
Anxiety, Burning sensation, Eye disorder, Hypoaesthesia, Insomnia, Rash macular, Joint swelling, Paraesthesia, Peripheral swelling, Pruritus, Rash, Skin irritation, Urticaria, Injection site swelling, Injection site pain, Injection site mass, Injection site bruising, Drug ineffective, Inappropriate schedule of product administration, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 434 | 25771813 |
US |
2 | |
Balance disorder, Euphoric mood, Visual impairment, Mental disorder, Hangover, Paraesthesia, Somnolence, Dizziness, Off label use, Product use in unapproved indication, Incorrect dose administered, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 435 | 25771968 |
CA |
||
Abdominal pain, Back pain, Chills, Diverticulitis, Fibromyalgia, Hyperhidrosis, Musculoskeletal pain, Nausea, Paraesthesia, Skin plaque, Upper-airway cough syndrome, Urticaria, Vaccine interaction, Weight increased, Injection site swelling, Drug ineffective, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MONTELUKAST SODIUM, |
||||
| 436 | 25771975 |
GB |
24 | 2 |
Paraesthesia, Dyspnoea, Mydriasis, Peripheral coldness, Logorrhoea, Insomnia, Psychomotor hyperactivity, Repetitive strain injury, Visual impairment, Anxiety, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, LANSOPRAZOLE, |
||||
| 437 | 25771999 |
CA |
||
Condition aggravated, Concussion, Weight decreased, Dyspnoea, Insomnia, Lice infestation, Paraesthesia, Urticaria, Anaphylactic reaction, Injection site swelling, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 438 | 25772330 |
CA |
||
Anaemia, Back injury, Back pain, Blood pressure systolic increased, Chlamydial infection, Depressed mood, Dry mouth, Emotional disorder, Hepatic fibrosis, Inflammation, Intervertebral disc protrusion, Ligament sprain, Metabolic dysfunction-associated steatohepatitis, Movement disorder, Myalgia, Psoriasis, Rosacea, Skin burning sensation, Symptom recurrence, Erythema, Paraesthesia, Pruritus, Rash, Swelling, Urticaria, Illness, Headache, Injection site pain, Inappropriate schedule of product administration, Therapeutic response decreased, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 439 | 25772892 |
IN |
50 | 2 |
Cardiac arrest, Non-cardiogenic pulmonary oedema, Shock, Acute kidney injury, Capillary leak syndrome, Toxicity to various agents, Metabolic acidosis, Confusional state, Dizziness, Hyperhidrosis, Paraesthesia, Hypoaesthesia, Vomiting, Hypotension, Pyrexia, White blood cell count increased, Heart rate increased, Pleural effusion, Intentional overdose, |
||||
AMLODIPINE, |
||||
| 440 | 25773046 |
GB |
32 | 2 |
Confusional state, Euphoric mood, Hypoaesthesia, Fatigue, Paraesthesia, Dizziness, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 441 | 25773058 |
US |
||
Pruritus, Muscle tightness, Lip swelling, Flushing, Insomnia, Paraesthesia, Hot flush, Feeling abnormal, Drug hypersensitivity, |
||||
CARVEDILOL, CLONIDINE, SPIRONOLACTONE, |
||||
| 442 | 25773294 |
EU |
47 | 2 |
Cyanosis, Skin necrosis, Paraesthesia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 443 | 25773389 |
US |
71 | 2 |
Neuropathy peripheral, Depression, Paraesthesia, Fatigue, Recalled product administered, Poor quality product administered, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, |
||||
| 444 | 25773428 |
US |
62 | 2 |
Off label use, Paraesthesia, Asthenia, Dizziness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 445 | 25773531 |
EU |
79 | 1 |
Rhabdomyolysis, Hepatic cytolysis, Paraesthesia, |
||||
SEMAGLUTIDE, SIMVASTATIN, METOPROLOL TARTRATE, METOPROLOL, TICAGRELOR, VALSARTAN, VALSARTAN ORAL, |
||||
| 446 | 25773755 |
US |
74 | 2 |
Neck pain, Electric shock sensation, Hypoaesthesia, Paraesthesia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 447 | 25774331 |
PR |
72 | 2 |
Paraesthesia oral, Tooth disorder, Paraesthesia, Pain, |
||||
POMALIDOMIDE, DARATUMUMAB, AMOXICILLIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 448 | 25774534 |
CA |
9 | 1 |
Colitis, Enteritis, Acne, Paraesthesia, Off label use, |
||||
USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 449 | 25774642 |
EU |
34 | 2 |
Neutropenia, Gastrointestinal disorder, Paraesthesia, Muscle spasms, Dyspnoea exertional, Injection site pain, Erythema, Anaemia, Asthenia, Epistaxis, |
||||
PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 450 | 25774647 |
EU |
60 | 2 |
Presyncope, Cough, Neutropenia, Constipation, Paraesthesia, Epistaxis, Weight decreased, Abdominal pain, Gastrointestinal disorder, Rhinitis, Myalgia, Rash, Asthenia, Hyperkalaemia, Anaemia, Dysaesthesia, |
||||
PACLITAXEL, PEMBROLIZUMAB, CARBOPLATIN, |
||||
| 451 | 25778742 |
59 | 2 | |
Atrial fibrillation, Diabetic ketoacidosis, Hypoaesthesia, Paraesthesia, Asthenia, Systemic inflammatory response syndrome, |
||||
DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, |
||||
| 452 | 25779263 |
71 | 2 | |
Muscular weakness, Paraesthesia, Dysstasia, Gait disturbance, Weight decreased, |
||||
EMPAGLIFLOZIN, LEVOTHYROXINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LOSARTAN, MONTELUKAST SODIUM, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EZETIMIBE, ERGOCALCIFEROL, |
||||
| 453 | 25779628 |
10 | 2 | |
Myalgia, Arthralgia, Neuralgia, Paraesthesia, Hypoaesthesia, Gait inability, Incontinence, Laboratory test abnormal, |
||||
DENOSUMAB, ERGOCALCIFEROL, VITAMIN E, MAGNESIUM, FISH OIL, |
||||
| 454 | 25769240 |
CA |
||
Back pain, Blood pressure systolic increased, Chronic spontaneous urticaria, Deformity, Fall, Injury, Stress, COVID-19, Paraesthesia, Pruritus, Rash, Urticaria, Viral infection, Arthralgia, Influenza, Nasopharyngitis, Drug ineffective, Inappropriate schedule of product administration, Incorrect dose administered, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DOXEPIN, DOXEPIN HYDROCHLORIDE, MONTELUKAST, ROSUVASTATIN CALCIUM, |
||||
| 455 | 25769516 |
US |
2 | |
Anxiety, Hypotension, Dizziness, Paraesthesia, Drug hypersensitivity, Accidental overdose, |
||||
TREPROSTINIL, TREPROSTINIL, MOMETASONE FUROATE, MOMETASONE, ACETAMINOPHEN, ESOMEPRAZOLE MAGNESIUM, MAGNESIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, ALBUTEROL SULFATE, TADALAFIL, MACITENTAN, ZOLPIDEM TARTRATE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, MECLIZINE HYDROCLORIDE, BUSPIRONE HYDROCHLORIDE, OXYGEN, 0XYGEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MIDODRINE HYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, GABAPENTIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ONDANSETRON HYDROCHLORIDE, TORSEMIDE, |
||||
| 456 | 25763229 |
US |
1 | |
Pharyngeal paraesthesia, Paraesthesia, |
||||
68GA-DOTATATE, |
||||
| 457 | 25763457 |
EU |
81 | 2 |
Palpitations, Muscle spasms, Pain, Hypoaesthesia, Paraesthesia, Fatigue, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, APIXABAN, DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EZETIMIBE, AMLODIPINE, DOXAZOSIN MESYLATE, BISOPROLOL FUMARATE, SIMVASTATIN, |
||||
| 458 | 25763982 |
US |
1 | |
Viral infection, Cutaneous T-cell lymphoma recurrent, Intentional product use issue, Off label use, Paraesthesia, Skin exfoliation, Condition aggravated, Application site erythema, Rash macular, Eczema, |
||||
MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, METOPROLOL TARTRATE, METOPROLOL, BEMPEDOIC ACID AND EZETIMIBE, |
||||
| 459 | 25764110 |
US |
58 | 2 |
Miliaria, Peripheral vascular disorder, Paraesthesia, Feeling hot, Blood pressure increased, Hypoaesthesia, Heart rate increased, Anxiety, Injection site pain, Hypersensitivity, Inappropriate schedule of product administration, |
||||
GALCANEZUMAB-GNLM, |
||||
| 460 | 25764261 |
US |
86 | 2 |
Eye pain, Lacrimation increased, Eye irritation, Product dose omission issue, Paraesthesia, Ocular hyperaemia, |
||||
CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, NETARSUDIL, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, BRIMONIDINE TARTRATE, CARBAMAZEPINE, |
||||
| 461 | 25764561 |
US |
1 | |
Paraesthesia, Eye pain, |
||||
CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, |
||||
| 462 | 25764848 |
AU |
||
Death, Somnolence, Gait disturbance, Paraesthesia, Blister, Skin exfoliation, Chills, Erythema, Pruritus, Pyrexia, Arthralgia, Hair colour changes, Drug ineffective, Product dose omission issue, |
||||
TEBENTAFUSP, |
||||
| 463 | 25764852 |
EU |
49 | 1 |
Paraesthesia, |
||||
IODIXANOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 464 | 25765157 |
US |
1 | |
Injection site paraesthesia, Paraesthesia, Pharyngeal paraesthesia, |
||||
68GA-DOTATATE, |
||||
| 465 | 25765684 |
US |
57 | 1 |
Paraesthesia, |
||||
HYDROCHLOROTHIAZIDE, LENVATINIB, PEMBROLIZUMAB, CHLORTHALIDONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 466 | 25766195 |
US |
76 | 2 |
Paraesthesia, Malaise, Product dose omission issue, Photophobia, Eyelid oedema, Eye pain, Fatigue, Erythema, Pigmentation disorder, Lymphoedema, Eye irritation, Rash, |
||||
CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, AMLODIPINE BESYLATE, TOPIRAMATE, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE, COLESEVELAM HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, QUETIAPINE, LEVOTHYROXINE SODIUM, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, CLOPIDOGREL, CALCIUM, ATORVASTATIN CALCIUM, ALPRAZOLAM, GABAPENTIN, PROPYLENE GLYCOL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 467 | 25766497 |
GB |
2 | |
Neuropathy peripheral, Paraesthesia, Diarrhoea, Nausea, Constipation, |
||||
GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BUPRENORPHINE, BUPRENORPHINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, MORPHINE SULFATE, |
||||
| 468 | 25766847 |
CA |
||
Wound, Abdominal discomfort, Abdominal pain upper, Alopecia, Arthropathy, Glossodynia, Hand deformity, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lung disorder, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Neck pain, Onychomadesis, Osteoarthritis, Pain, Paraesthesia, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Helicobacter infection, Lower respiratory tract infection, Drug intolerance, Treatment failure, Drug ineffective, Live birth, Maternal exposure during pregnancy, Therapeutic product effect incomplete, Product use issue, Product use in unapproved indication, Intentional product use issue, Intentional product use issue, Underdose, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CYCLOBENZAPRINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, ERGOCALCIFEROL, ERGOCALCIFEROL, AZELAIC ACID, AZELAIC ACID, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVOMILNACIPRAN, MAGNESIUM CHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, OXYCODONE, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, PHOSPHORUS, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RANITIDINE, RANITIDINE, RANITIDINE, RANITIDINE, RANITIDINE, RANITIDINE, RANITIDINE, RANITIDINE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRETINOIN, TRETINOIN, TOFACITINIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 469 | 25766916 |
CA |
71 | 1 |
Arthralgia, Musculoskeletal stiffness, Headache, Limb discomfort, Carpal tunnel syndrome, Myalgia, Staphylococcal infection, Visual impairment, Paraesthesia, |
||||
PREDNISONE, CANDESARTAN, PANTOPRAZOLE, PANTOPRAZOLE, RIVAROXABAN, HYDROXYCHLOROQUINE SULFATE, RIVAROXABAN, TOCILIZUMAB, CANNABIDIOL, HYDROCHLOROTHIAZIDE, GABAPENTIN, |
||||
| 470 | 25767117 |
US |
76 | 2 |
Paraesthesia, Hypoaesthesia, Pain in extremity, Arthralgia, |
||||
DUPILUMAB, |
||||
| 471 | 25767476 |
EU |
42 | 2 |
Anxiety, Thirst, Polydipsia, Urinary retention, Dysuria, Vomiting, Nausea, Paraesthesia, Tinnitus, Drug interaction, Drug ineffective, Drug ineffective for unapproved indication, Off label use, |
||||
DIMENHYDRINATE, DIMENHYDRINATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, DIMENHYDRINATE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, AMLODIPINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, DULOXETINE HYDROCHLORIDE, DULOXETINE, MORPHINE, MORPHINE, OLANZAPINE, OLANZAPINE, PREGABALIN, PREGABALIN, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 472 | 25767596 |
CA |
1 | |
Non-small cell lung cancer, Pain in extremity, Hypoaesthesia, Paraesthesia, |
||||
BRIGATINIB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SENNOSIDES, SENNA LEAF, SENNA, |
||||
| 473 | 25768136 |
US |
2 | |
Eye pain, Eye irritation, Paraesthesia, |
||||
CENEGERMIN-BKBJ, LINACLOTIDE, SIMVASTATIN, TEMAZEPAM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, ERYTHROMYCIN, |
||||
| 474 | 25768615 |
US |
72 | 1 |
Paraesthesia, Muscle spasms, |
||||
LENALIDOMIDE, |
||||
| 475 | 25768628 |
GB |
50 | 2 |
Brain fog, Headache, Decreased appetite, Paraesthesia, Asthenia, Nausea, Dizziness, Fatigue, Medication error, |
||||
| 476 | 25768916 |
US |
2 | |
Muscle spasms, Asthenia, Paraesthesia, Feeling abnormal, Eye disorder, Hypoglycaemia, Blood glucose abnormal, Anion gap increased, Blood albumin increased, |
||||
SECUKINUMAB, |
||||
| 477 | 25769005 |
SA |
33 | 2 |
Throat irritation, Hypoaesthesia, Paraesthesia, Cough, |
||||
EPTINEZUMAB-JJMR, GALCANEZUMAB-GNLM, RIMEGEPANT SULFATE, |
||||
| 478 | 25769162 |
US |
80 | 2 |
Nervousness, Paraesthesia oral, Paraesthesia, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 479 | 25774072 |
41 | 2 | |
Hypoaesthesia, Paraesthesia, |
||||
TIRZEPATIDE, |
||||
| 480 | 25758387 |
CA |
46 | 2 |
Chest discomfort, Oropharyngeal pain, Dyspnoea, Paraesthesia, |
||||
LEUCOVORIN CALCIUM, OLANZAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, DALTEPARIN SODIUM, PEGFILGRASTIM, PANTOPRAZOLE, PROCHLORPERAZINE, |
||||
| 481 | 25758457 |
AU |
48 | 2 |
Vomiting, Chest discomfort, Dyspnoea, Electrocardiogram T wave inversion, Flushing, Hyperhidrosis, Paraesthesia, Rhinorrhoea, Sinus tachycardia, Throat irritation, Cough, |
||||
CARBOPLATIN, |
||||
| 482 | 25758518 |
IN |
||
Withdrawal syndrome, Drug dependence, Irritability, Restlessness, Feeling jittery, Insomnia, Headache, Vomiting, Paraesthesia, Pain in extremity, Intentional overdose, Drug abuse, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 483 | 25758695 |
US |
1 | |
Paraesthesia, Sensory loss, Injection site reaction, |
||||
DUPILUMAB, |
||||
| 484 | 25759194 |
EU |
2 | |
Neutropenia, Paraesthesia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, |
||||
| 485 | 25759475 |
US |
22 | |
Paraesthesia, Muscle spasms, Pain, Discomfort, Contusion, Skin discolouration, |
||||
POLIDOCANOL, |
||||
| 486 | 25759505 |
US |
72 | 2 |
Peripheral swelling, Paraesthesia, Pain in extremity, |
||||
POLIDOCANOL, |
||||
| 487 | 25759866 |
BR |
61 | 2 |
Syncope, Rheumatoid arthritis, Chronic gastritis, Lactose intolerance, Rash macular, Paraesthesia, Nausea, Depression, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 488 | 25760228 |
US |
2 | |
Urticaria, Paraesthesia, Erythema, Off label use, Feeling hot, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 489 | 25760294 |
US |
45 | 1 |
Paraesthesia, Nerve compression, |
||||
DUPILUMAB, |
||||
| 490 | 25761315 |
EU |
60 | 2 |
Presyncope, Hyperkalaemia, Neutropenia, Gastrointestinal disorder, Weight decreased, Cough, Dysaesthesia, Rash, Myalgia, Abdominal pain, Epistaxis, Paraesthesia, Rhinitis, Asthenia, Constipation, Anaemia, Off label use, |
||||
PACLITAXEL, CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 491 | 25761318 |
CA |
72 | 2 |
Adverse event, Arthralgia, Back pain, Blood creatinine increased, Bursitis, Deafness, Disease progression, Disease recurrence, Drug intolerance, Dry mouth, Electric shock sensation, Feeling abnormal, Gait disturbance, Glomerular filtration rate decreased, Headache, Hypersensitivity, Hypoaesthesia, Inflammation, Inflammatory marker increased, Joint swelling, Limb discomfort, Movement disorder, Musculoskeletal discomfort, Musculoskeletal stiffness, Neck pain, Nerve compression, Pain, Pain in extremity, Pain in jaw, Paraesthesia, Polyarthritis, Tachycardia, Tinnitus, |
||||
TOFACITINIB, DICLOFENAC, DICLOFENAC SODIUM, LOSARTAN POTASSIUM, LOSARTAN, LEFLUNOMIDE, TRAMADOL HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 492 | 25761410 |
EU |
70 | 1 |
Hyponatraemia, Headache, Paraesthesia, Neuralgia, Hyperhidrosis, Gait disturbance, |
||||
OXCARBAZEPINE, OXCARBAZEPINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, APIXABAN, PREGABALIN, |
||||
| 493 | 25761642 |
EU |
59 | 2 |
Neuropathy peripheral, Neuralgia, Muscle discomfort, Nervous system disorder, Paraesthesia, Palpitations, Palpitations, |
||||
EZETIMIBE, |
||||
| 494 | 25761646 |
US |
||
Chronic inflammatory demyelinating polyradiculoneuropathy, Gait disturbance, Feeling jittery, Tremor, Loss of personal independence in daily activities, Weight increased, Rehabilitation therapy, Arthralgia, Paraesthesia, Headache, Therapy change, |
||||
EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT), EFGARTIGIMOD ALFA, |
||||
| 495 | 25761702 |
EU |
74 | 2 |
Gravitational oedema, Paraesthesia, Anaemia, Asthenia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PACLITAXEL, |
||||
| 496 | 25761763 |
GB |
86 | 2 |
Poor quality sleep, Paraesthesia, Dysgeusia, Tongue discolouration, |
||||
CLARITHROMYCIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RIVAROXABAN, SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE TABLES AF, SOTALOL HYDROCHLORIDE TABLETS AF, |
||||
| 497 | 25761897 |
US |
2 | |
Seizure, Paraesthesia, Feeling abnormal, Tinnitus, Speech disorder, Dysgraphia, Reading disorder, Anger, |
||||
LEVETIRACETAM, LEVETIRACETAM, LISINOPRIL, ZOLPIDEM TARTRATE, |
||||
| 498 | 25762060 |
US |
59 | 1 |
Coma, Depression, Non-Hodgkin^s lymphoma, Insomnia, Restless legs syndrome, Amnesia, Dyschromatopsia, Somnolence, Fatigue, Asthenia, Decreased appetite, Disturbance in attention, Paraesthesia, Loss of consciousness, Atrial fibrillation, Pneumonia, Inappropriate schedule of product administration, |
||||
DEUTETRABENAZINE, |
||||
| 499 | 25763094 |
US |
1 | |
Blood pressure increased, Intracranial aneurysm, Paraesthesia, Agitation, Malaise, Panic attack, Heart rate decreased, |
||||
ALIROCUMAB, |
||||
| 500 | 25763102 |
GB |
2 | |
Prolapse, Tremor, Therapeutic product effect incomplete, Dystonia, Paraesthesia, Medical device discomfort, Depressed mood, Tearfulness, Constipation, |
||||
CARBIDOPA AND LEVODOPA, CLONAZEPAM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30